Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 255 | 3 | IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY | 46035 |
| 2637 | 2 | CANCER IMMUNOLOGY IMMUNOTHERAPY//NEWCASTLE DISEASE VIRUS//ANTITUMOR RESISTANCE | 3739 |
| 16538 | 1 | THYMIC IMMUNE REACTIVITY//CANCER IMMUNOLOGY IMMUNOTHERAPY//ANTIGEN SHEDDING | 675 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | THYMIC IMMUNE REACTIVITY | authKW | 93381 | 0% | 100% | 2 |
| 2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 89128 | 14% | 2% | 92 |
| 3 | ANTIGEN SHEDDING | authKW | 77810 | 1% | 33% | 5 |
| 4 | ADOPTIVE CHEMOIMMUNOTHERAPY | authKW | 62252 | 0% | 67% | 2 |
| 5 | DRUG RESISTANT TUMORS | authKW | 62252 | 0% | 67% | 2 |
| 6 | ACTIVE SPECIFIC CHEMOIMMUNOTHERAPY | authKW | 46690 | 0% | 100% | 1 |
| 7 | ADJUNCTIVE CANCER TREATMENT | authKW | 46690 | 0% | 100% | 1 |
| 8 | ANTIGENIC RAT FIBROSARCOMA | authKW | 46690 | 0% | 100% | 1 |
| 9 | AP2 TEST | authKW | 46690 | 0% | 100% | 1 |
| 10 | AUTOLOGOUS TUMOR SENSITIZED KILLER CELLS | authKW | 46690 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 6685 | 52% | 0% | 348 |
| 2 | Immunology | 5223 | 42% | 0% | 284 |
| 3 | Pharmacology & Pharmacy | 446 | 17% | 0% | 115 |
| 4 | Allergy | 214 | 3% | 0% | 19 |
| 5 | Medicine, Research & Experimental | 88 | 5% | 0% | 37 |
| 6 | Pathology | 51 | 3% | 0% | 21 |
| 7 | CYTOLOGY & HISTOLOGY | 21 | 0% | 0% | 2 |
| 8 | Hematology | 17 | 2% | 0% | 16 |
| 9 | Toxicology | 5 | 2% | 0% | 11 |
| 10 | Transplantation | 4 | 1% | 0% | 6 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANC DRUG GRACE 347 | 46690 | 0% | 100% | 1 |
| 2 | CYTOKINES CANC | 46690 | 0% | 100% | 1 |
| 3 | EXTREME BODY CONDIT STUDY | 46690 | 0% | 100% | 1 |
| 4 | IMMUNOL INERNAL DIS | 46690 | 0% | 100% | 1 |
| 5 | MICROBIOL IMMUNOL MC 790 BOX 6998 | 46690 | 0% | 100% | 1 |
| 6 | PROGRAMA MAESTRIA CIENCIAS MEDICASIMSS | 46690 | 0% | 100% | 1 |
| 7 | UNIT 442CHILDRENS CANC HOSP | 46690 | 0% | 100% | 1 |
| 8 | CUALTOS | 38197 | 0% | 27% | 3 |
| 9 | GRACE CANC DRUG | 28512 | 2% | 6% | 11 |
| 10 | HEMATOPOIET DISORDERS | 7780 | 0% | 17% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 89128 | 14% | 2% | 92 |
| 2 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 35028 | 6% | 2% | 39 |
| 3 | CANCER RESEARCH | 7562 | 12% | 0% | 80 |
| 4 | EKSPERIMENTALNAYA ONKOLOGIYA | 7376 | 2% | 1% | 14 |
| 5 | IMMUNOPHARMACOLOGY | 3496 | 1% | 1% | 10 |
| 6 | GANN | 3053 | 1% | 1% | 7 |
| 7 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2631 | 2% | 0% | 16 |
| 8 | CLINICS IN IMMUNOLOGY AND ALLERGY | 2556 | 0% | 2% | 3 |
| 9 | METHODS IN CANCER RESEARCH | 2455 | 0% | 5% | 1 |
| 10 | JOURNAL OF IMMUNOPHARMACOLOGY | 2074 | 0% | 1% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |